News

Aurobindo Pharma rallies after receiving USFDA nod for Rivaroxaban tablets
Aurobindo Pharma jumped 3.42% to Rs 1,119.55 after the pharma company said that it has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban ...
What is Bucks guard Damian Lillard's injury status heading into the NBA playoffs?
What is the latest injury status of Damian Lillard as the Milwaukee Bucks begin the NBA playoffs in Indianapolis against the ...
Clinical Advisor16h
AHA Scientific Statement on Disparities in Pulmonary Embolism Treatment and Outcomes
The AHA has published a scientific statement regarding disparities in current pulmonary embolism management and outcomes.
Drug Store News18h
Aurobindo Pharma receives FDA OK for generic Xarelto
Generic Xarelto is a blood thinner medicine that lowers blood clotting. Aurobindo has obtained the Food and Drug ...
Medical Dialogues1d
Aurobindo Pharma gets USFDA final, tentative nod for different strengths of deep vein thrombosis drug Rivaroxaban
Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market RivaroxabanTablets USP, 2.5 mg, which ...
Aurobindo Pharma gets USFDA nod for Rivaroxaban tablets
Aurobindo Pharma said that it has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg.
Aurobindo Pharma’s Rivaroxaban Tablets get U.S FDA nod
Aurobindo Pharma gains FDA approval to manufacture and market Rivaroxaban Tablets USP, with plans to launch by June.
Austin American-Statesman6d
Milwaukee Bucks guard Damian Lillard has a blood clot in his leg. What is deep vein thrombosis?
Yes, it can be very serious. If left untreated, clots can block blood flow to the heart if a pulmonary embolism develops (blood clot in the lungs). Inflammation from an infection or injury are ...